Abstract:Angiogenesis plays an important role in tumor initiation and progression of glioma. Seeking for biomarkers associated with angiogenesis is important in enhancing our understanding of glioma biologically and identifying its new drug targets. RNA-sequencing (RNA-seq) data and matched clinical data were downloaded from the CGGA database. A series of filtering analyses were performed to screen for reliable genes: survival, multivariate Cox, ROC curve filtration, and clinical correlation analyses. After immunohistochemical verification, RAB42 was identified as a reliable gene for further single gene analysis. Afterwards, we performed gene set enrichment analysis (GSEA) and co-expression analysis to establish the related molecular mechanisms and signal pathways in glioma. Finally, the gene functions and the mechanisms were investigated in vitro experiments. A total of 23270 mRNA expression and 1018 glioma samples were included in this study. After the three filtering analyses, we selected ten genes for immunohistochemical verification: KLHDC8A, IKIP, HIST1H2BK, HIST1H2BJ, GNG5, FAM114A1, TMEM71, RAB42, CCDC18 , and GAS2L3 . Immunostaining demonstrated that RAB42 was significantly expressed on the membrane of glioma tissues but not in normal tissues. These results were verified and validated in GEPIA datasets, and the association between RAB42 with clinical features was also evaluated. Analysis of gene functions indicated that RAB42 activated VEGF signaling pathways and the mechanism was associated with natural killer cell mediated cytotoxicity, JAK-STAT signaling pathway and apoptosis pathways by PI3K/AKT in gliomas. Experiments in vitro suggested that the proliferation and invasion of glioma cells might be inhibited after downregulating of RAB42 . And the tumorigenesis promotion of RAB42 may relate to the activation of VEGF signaling pathway. Taken together, this study shows that the overexpression of RAB42 is an independent prognostic factor of adverse prognosis. Its pro-oncogenic mechanism may be associated with the activation of VEGF signaling pathways.

RAB1A Regulates Glioma Cellular Proliferation and Invasion Via the Mtor Signaling Pathway and Epithelial-Mesenchymal Transition.

RabGEF1 Functions As an Oncogene in U251 Glioblastoma Cells and is Involved in Regulating AKT and Erk Pathways

Rab32 promotes glioblastoma migration and invasion via regulation of ERK/Drp1-mediated mitochondrial fission

RAB32 promotes glioma cell progression by activating the JAK/STAT3 signaling pathway

High Expression of RAB43 Predicts Poor Prognosis and is Associated with Epithelial-Mesenchymal Transition in Gliomas.

RAB42 Promotes Glioma Pathogenesis via the VEGF Signaling Pathway

Rac GTPase activating protein 1 promotes the glioma growth by regulating the expression of MCM3

High Expression of RAB32 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioblastoma

RLIP76 is Overexpressed in Human Glioblastomas and is Required for Proliferation, Tumorigenesis and Suppression of Apoptosis.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

Overexpression of RAB34 Associates with Tumor Aggressiveness and Immune Infiltration in Glioma

Ott_a_247731 3073..3083

A Role for LRIG1 in the Regulation of Malignant Glioma Aggressiveness.

RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma

Downregulation of RNF138 Inhibits Cellular Proliferation, Migration, Invasion and EMT in Glioma Cells Via Suppression of the Erk Signaling Pathway

RIT1 Promotes Glioma Proliferation and Invasion via the AKT/ERK/NF-ĸB Signaling Pathway

Rab 13 silencing causes inhibition of growth and induction of apoptosis in human glioma cells

A Specific Isoform of Glial Cell Line‐derived Neurotrophic Factor Family Receptor Alpha 1 Regulates RhoA Expression and Glioma Cell Migration

The Role of Mir-451 in the Switching Between Proliferation and Migration in Malignant Glioma Cells: AMPK Signaling, Mtor Modulation and Rac1 Activation Required

LRIG1 regulates invasion and migration of human gliomas through SNAI2 and E-cadherin

NKCC1 Promotes EMT-like Process in GBM Via RhoA and Rac1 Signaling Pathways.